Pharm Exec’s Lisa Henderson, Scott Gottlieb, MD, Former FDA Commissioner, and experts from Parexel talk about the COVID-19 pandemic and how its enormous impact on our medical systems has accelerated the growth in and adoption of RWE.
A New Era of Real-World Evidence
Breaking New Ground with RWE
Real-World Evidence: State-of-the-Art, Current Challenges and Future Vision
Recent roundtable brought together by Pharm Exec and Parexel features insights from leaders in the pharma industry on the current state and future of RWE.